[Efficacy and safety of cyclophosphamide as a sequential immunotherapy drug for anti-N-methyl-D-aspartate receptor encephalitis in children].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics(2017)

Cited 2|Views17
No score
Abstract
Children with anti-NMDAR encephalitis should be given appropriate immunotherapy as soon as possible. Cyclophosphamide as a sequential therapy has good efficacy and safety.
More
Translated text
Key words
Anti-N-methyl-D-aspartate receptor encephalitis,Cyclophosphamide,Immunotherapy,Child
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined